"Cyclobutanes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
| Descriptor ID |
D003503
|
| MeSH Number(s) |
D02.455.426.392.368.201
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cyclobutanes".
Below are MeSH descriptors whose meaning is more specific than "Cyclobutanes".
This graph shows the total number of publications written about "Cyclobutanes" by people in this website by year, and whether "Cyclobutanes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 2 | 4 |
| 2021 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclobutanes" by people in Profiles.
-
Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer. Nucl Med Commun. 2021 Jul 01; 42(7):755-762.
-
Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT. Clin Nucl Med. 2021 Apr 01; 46(4):e240-e241.
-
Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer. Clin Nucl Med. 2021 Apr 01; 46(4):355-357.
-
Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT. Clin Nucl Med. 2021 Feb 01; 46(2):e114-e115.
-
18F-Fluciclovine Uptake in a Ureterocele. Clin Nucl Med. 2021 Jan; 46(1):e3-e5.
-
Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment? Clin Nucl Med. 2020 Sep; 45(9):672-678.
-
Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level =0.5?ng/mL. Nucl Med Commun. 2020 Sep; 41(9):906-915.
-
Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment. Clin Nucl Med. 2020 May; 45(5):349-355.
-
Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer. Clin Nucl Med. 2020 Apr; 45(4):e208-e210.
-
Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer. Nucl Med Commun. 2019 Sep; 40(9):940-946.